… Epigenetic therapy is a new and rapidly developing area and a potentially very useful form …
agent, is very unstable under physiological conditions. Another compound curcumin, a yellow …

… pathways that are responsible for the development and progression of various chronic …
Recent studies have also demonstrated the potential of curcumin in controlling epigenetic …

… development of novel hypomethylating agents that are more effective and have a more
favorable toxicity profile are essential to broaden the spectrum of epigenetic … of epigenetically …

… They are required to maintain normal growth, development and gene expression in different
… to investigate the epigenetic effect of curcumin as a demethylating agent with consequence …

… curcumin analogues also exhibit biological activity. This Review describes the development
of curcumin from a … of curcumin appears to be of central importance for epigenetic regulation …

… (HDACi), a promising new class of antineoplastic agents. … developments in the field of
HDACi for lymphoma therapy. … of curcumin as therapy for patients with refractory HD [79]. …

… -particle form of curcumin was developed that has a higher … cancer is associated with epigenetic
and genetic alterations which … proteins promotes tumor development and metastasis, as …

… properties of curcumin is that inflammation is one of the factors for cancer development and
this … Numerous articles described curcumin’s antitumor activity on several different mailgnant …

… In cancer cells, sulforaphane acts as an effective chemopreventive and natural anti-tumoral
agent. Curcumin acts as a hypomethylating agent for breast cancer therapy. Curcumin …

… Beyond the success of herceptin and gleevec, the development of mono-targeted cancer …
spective of genetic or epigenetic alterations that contribute to the development of cancer, the …